News View all news
DIR reform in updated Senate bill welcome news to pharmacists and advocates
Senate Finance Committee leaders Sens. Chuck Grassley (R-IA) and Ron Wyden (D-OR) have released a new drug pricing bill that includes language that would require price concessions to be included in the negotiated price at point of sale (POS) under Medicare Part D. The change would take effect on January 1, 2022. The bipartisan S. 2543, the Prescription Drug Pricing Reduction Act, would also prohibit plans from retroactively recouping fees while allowing post-POS bonuses and moves up the timeline for standard quality metrics to 2022. Read the new language addressing direct and indirect remuneration (DIR fees) and other pharmacy issues here.
Senate confirms Stephen Hahn to head FDA
With a vote of 72-18, the Senate voted on Thursday to confirm noted oncologist Stephen Hahn as commissioner of the FDA. Hahn, chief medical executive at the University of Texas MD Anderson Cancer Center, was nominated by President Trump to replace Scott Gottlieb, MD, who stepped down from the position earlier this year.
Too much vitamin D may cause bone harm, study finds
While the full scope of vitamin D’s effects on areas such as cardiovascular and mental health remains unclear, it has long been established that the nutrient is essential in maintaining strong bones and muscles. But a recent study published in JAMA revealed that taking too much vitamin D may be harmful.
Walmart will continue accepting paper prescriptions in 2021, but for how long?
Beginning in January, six more states will require electronic, or e-prescriptions for controlled substances, which include opioid analgesics. A year later, Medicare Part D will require controlled substances prescriptions to be submitted electronically.
November 26, 2019
Thank you for all you do
Every day, you model the reasons that pharmacists must be increasingly incorporated into growing patient care roles across the health care spectrum. Yet, it’s little comfort to many of our own who…0 comments
December 10, 2019
Pharmacy Coalition Applauds Needed Pharmacy Patient Reforms in Bipartisan Drug Pricing Package
A coalition of national pharmacy groups today applauded the latest version of the bipartisan Prescription Drug Pricing Reduction Act, released Friday by the Senate Finance Committee, which they say addresses backdoor clawback fees charged by large pharmacy benefit managers (PBMs) that are shuttering pharmacies and costing patients more at the pharmacy counter.
November 5, 2019
APhA supports innovative legislation to reduce drug shortages
The American Pharmacists Association (APhA) today expressed its support for a bill that will provide new opportunities to address drug shortages and improve care. The Mitigating Emergency Drug Shortages (MEDS) Act, introduced by Sens. Susan Collins (R-ME) and Tina Smith (D-MN), aims to improve communications to pharmacists about drug shortages and mitigate the risks drug shortages pose to patient safety, among other benefits.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.